Results 121 to 130 of about 8,852 (197)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations [PDF]

, 2020
Ruiz Simonato Alonso, Helena Parente Solari, Eduardo de França Damasceno, Miguel Noel Nascentes Burnier, Marcelo Palis Ventura   +4 more
openalex   +1 more source

Brimonidine [PDF]

, 2020
National Cancer Institute
openalex   +1 more source

Modification of contact lenses via metal‐organic frameworks for glaucoma treatment

Aggregate
The prevention of blindness from glaucoma requires multiple treatments to lower intraocular pressure. Here, human contact lenses are modified with highly porous metal‐organic frameworks with sustained release of brimonidine for prolonged glaucoma ...
Alexey V. Yaremenko, Roman O. Melikov, Nadezhda A. Pechnikova, Iaroslav B. Belyaev, Alina Ringaci, Tamara V. Yaremenko, Aziz B. Mirkasymov, Alexandr A. Tamgin, Vladislav I. Rodionov, Sofya M. Dolotova, Grigory A. Plisko, Evgeny D. Semivelichenko, Anna S. Rogova, Albert R. Muslimov, Arina S. Ivkina, Dmitry Yu. Ivkin, Valery P. Erichev, Sergey M. Deyev, Sergey E. Avetisov, Yongjiang Li, Hai‐Jun Liu, Ivan V. Zelepukin   +21 more
doaj   +1 more source

ION-SELECTIVE MEMBRANE SENSORS FOR DETERMINATION OF BRIMONIDINE TARTRATE IN BULK POWDER, PHARMACEUTICAL EYEDROPS AND BIOLOGICAL FLUIDS. [PDF]

, 2018
H.S. Daabees, Wael Talaat, ManalEl Shal, Kholoud Ahmed   +3 more
openalex   +1 more source

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure

Clinical Ophthalmology, 2008
Anne J Lee1, Peter McCluskey1,21Department of Ophthalmology, Liverpool Hospital, Liverpool, NSW, Australia; 2Faculty of Medicine, University of New South Wales, Randwick, NSW, AustraliaAbstract: Lowering IOP is the most readily modifiable risk factor to ...
Anne J Lee, Peter McCluskey
doaj  

Crystal structure of brimonidine hydrogen tartrate, (C ₁₁ H ₁₁ BrN ₅ )(HC ₄ H ₄ O ₆ ) [PDF]

James A. Kaduk, Anja Došen, Thomas N. Blanton   +2 more
openalex   +1 more source

Twenty-four hour efficacy of glaucoma medications [PDF]

, 2015
Katsanos, Andreas, Konstas, Anastasios G. P., Mikropoulos, Dimitrios G., QUARANTA, Luciano, Teus, Miguel A., Tranos, Paris G.   +5 more
core   +1 more source

Ophthalmic Drugs 2015 [PDF]

A handy reference about ophthalmic drugs for students and clinicians in eye care ...
Helmus, Julie A, Koh, Len V
core   +1 more source

Clinical superiority of either of topical 0.5% apraclonidine, 0.2% brimonidine and 0.03% bimatoprost given prophylactically in managing intraocular pressure spikes following Nd:YAG laser posterior capsulotomy [PDF]

, 2021
Tahir Husain Ansari, Pranav Gupta, Yusuf Rizvi, Mohd. Haroon Khan   +3 more
openalex   +1 more source

Allergic Reactions to Brimonidine 0.15%: A Case Series. [PDF]

Cureus
Mat Nawi FN, Bastion MC.
europepmc   +1 more source